Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

Continued Access to RXDX-105

See Locations Near You

Summary

This study is being done to see if people with Non-Small Cell Lung Cancer (NSCLC) or ovarian cancer benefit from continued treatment with the study drug, RXDX-105.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

This individual patient protocol includes treatment for 3 patients previously enrolled on IRB #15-270 (phase1/1b clinical trial RXDX-105-01):

Exclusion Criteria:

Any patients other than those described above are excluded.

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

3

Study ID:

NCT03784378

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center 1275 York Avenue
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

3

Study ID:

NCT03784378

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Promising Immunotherapy Trials for Ovarian Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider